LION licenses integration platform SRS to Affymetrix

17 May 2001

Germany's LION Bioscience has granted a license on its integrationsystem SRS to USA-based Affymetrix so the latter can build a web portal for its customers, as well as for internal use. The web portal will supply detailed information relating to Affymetrix' GeneChip probe arrays and related products.

SRS, which was also used for the Celera Discovery System, integrates diverse data through one interface and is the basis for LION's R&D knowledge management solutions, which it brand names i-biology.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight